Peer-reviewed publications, clinical trials, and case studies from HUKM specialists — freely accessible to the medical community.
A prospective cohort study of 2,412 patients evaluating a deep-learning ECG classifier against consultant cardiologists for early ischemic detection. The model achieved AUC 0.94, outperforming standard triage in the ≥45 age group by 11%.
Retrospective analysis of 486 NPC patients treated with checkpoint inhibitors between 2020–2025. Median PFS improved from 8.2 to 14.6 months versus historic chemotherapy controls.
Randomised controlled trial (n=180) comparing conventional physiotherapy versus VR-guided motor rehabilitation. VR arm showed 27% greater Fugl-Meyer improvement at 12 weeks.
Case series of 214 robotic-assisted TKAs. Component alignment within 2° in 96% of cases; 30-day readmission 2.3% vs national benchmark 4.8%.
Cross-sectional study of 1,240 pregnancies. Screening compliance rose from 62% to 88% after community nurse outreach, correlating with 34% fewer macrosomic births.
Prospective evaluation of an LLM-based triage chatbot across 3,180 pediatric ED encounters. Concordance with senior triage nurses 92%; no missed high-acuity cases.
Meta-analysis of 42 studies covering 2015–2024. Indonesian and Bangladeshi inbound patient volume forecast to grow 34% YoY through 2028.
Comparative study of symptom recall accuracy across Bahasa Malaysia, English, Mandarin, Tamil and Arabic inputs. Accuracy delta closed to <3% with fine-tuned models.
Gradient-boosted model forecasting ICU occupancy 14 days ahead. MAPE 7.4% during 2023 flu season, enabling proactive staffing and reducing overflow by 22%.
Two-year registry of 612 post-MI patients. 78% achieved target functional capacity; adherence to Mediterranean-style diet was the strongest predictor of PROM improvement.
Mixed-methods study of 420 participants aged 60+. Language and interface simplicity were the top adoption drivers; smartphone literacy programmes lifted uptake 41%.
Review of 1,850 executive screening participants. Downstream detection of stage-I cancer and pre-diabetes yielded RM 3.2M in avoided treatment costs over 3 years.